Variant: rs2151280 

    present in Gene: CDKN2B-AS1
    present in Chromosome: 9
    Position on Chromosome: 22034720
    Alleles of this Variant: G/A

rs2151280 in CDKN2B-AS1 gene and Basal Cell Cancer PMID 24403052 2014 Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.

PMID 25855136 2015 New basal cell carcinoma susceptibility loci.

rs2151280 in CDKN2B-AS1 gene and Basal Cell Neoplasm PMID 24403052 2014 Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.

PMID 25855136 2015 New basal cell carcinoma susceptibility loci.

rs2151280 in CDKN2B-AS1 gene and Basal cell carcinoma PMID 25855136 2015 New basal cell carcinoma susceptibility loci.

PMID 24403052 2014 Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.

rs2151280 in CDKN2B-AS1 gene and Carcinoma, Basal Cell PMID 24403052 2014 Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.

rs2151280 in CDKN2B-AS1 gene and Glaucoma, Open-Angle PMID 22570617 2012 Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma.

rs2151280 in CDKN2B-AS1 gene and Glioma PMID 21531791 2011 Chromosome 7p11.2 (EGFR) variation influences glioma risk.